BidaskClub Lowers Catasys (NASDAQ:CATS) to Sell

Share on StockTwits

BidaskClub lowered shares of Catasys (NASDAQ:CATS) from a hold rating to a sell rating in a research note issued to investors on Tuesday, BidAskClub reports.

A number of other research analysts also recently issued reports on the company. Dougherty & Co initiated coverage on Catasys in a report on Tuesday, May 7th. They issued a buy rating for the company. TheStreet downgraded Stamps.com from a b- rating to a c+ rating in a report on Monday, March 11th. Finally, Canaccord Genuity decreased their price target on Cronos Group from C$17.00 to C$16.00 in a report on Friday, May 10th. One research analyst has rated the stock with a sell rating, five have given a buy rating and two have issued a strong buy rating to the stock. The company presently has an average rating of Buy and an average target price of $19.00.

Shares of NASDAQ CATS opened at $19.13 on Tuesday. The firm has a 50 day moving average price of $18.46. The stock has a market capitalization of $305.48 million, a price-to-earnings ratio of -21.49 and a beta of 1.66. Catasys has a 52 week low of $6.39 and a 52 week high of $20.83.

Catasys (NASDAQ:CATS) last issued its earnings results on Thursday, May 9th. The company reported ($0.18) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.24) by $0.06. The firm had revenue of $6.81 million during the quarter, compared to analysts’ expectations of $5.64 million. On average, equities analysts anticipate that Catasys will post -0.96 EPS for the current year.

In related news, major shareholder David E. Smith sold 16,692 shares of the stock in a transaction on Friday, May 10th. The stock was sold at an average price of $17.29, for a total value of $288,604.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder David E. Smith sold 135,773 shares of the stock in a transaction on Thursday, April 25th. The shares were sold at an average price of $14.99, for a total value of $2,035,237.27. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 401,811 shares of company stock valued at $6,465,985. Corporate insiders own 60.80% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. FNY Investment Advisers LLC acquired a new position in Catasys in the 1st quarter valued at $47,000. Baldwin Brothers Inc. MA raised its stake in Catasys by 22.2% in the 1st quarter. Baldwin Brothers Inc. MA now owns 27,500 shares of the company’s stock valued at $336,000 after purchasing an additional 5,000 shares during the last quarter. Geode Capital Management LLC raised its stake in Catasys by 27.2% in the 4th quarter. Geode Capital Management LLC now owns 28,315 shares of the company’s stock valued at $265,000 after purchasing an additional 6,050 shares during the last quarter. Northern Trust Corp raised its stake in Catasys by 95.2% in the 4th quarter. Northern Trust Corp now owns 19,634 shares of the company’s stock valued at $184,000 after purchasing an additional 9,578 shares during the last quarter. Finally, WINTON GROUP Ltd purchased a new stake in Catasys in the 2nd quarter valued at $227,000. 12.66% of the stock is owned by hedge funds and other institutional investors.

Catasys Company Profile

Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.

Read More: What is the formula for the cash asset ratio?

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.